Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

820 public trials 197 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Completed

A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)

NCT02913443

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • The Ottawa Hospital Cancer Centre; Oncology Ottawa, Ontario, Canada
  • University Health Network; Princess Margaret Hospital; Medical Oncology Dept Toronto, Ontario, Canada
  • Rigshospitalet; Onkologisk Klinik København Ø, Denmark
View Trial Details
Completed

A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer

NCT02874664

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
View all 15 locations
View Trial Details
Completed

Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer

NCT01901653

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

NCT00298896

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • University of California Davis Sacramento, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore, Maryland, United States
View all 17 locations
View Trial Details
Completed

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

NCT00527735

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Birmingham Hematology & Oncology Assoc. Llc Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Acrc/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • Compassionate Cancer Care Medical Group Corona, California, United States
View all 72 locations
View Trial Details

Related conditions